RE:RE:RE:RE:RE:RE:RE:Get ready for more merger mania in the pharma sector Thumbs up to the posts from Capitalista and Notable just below. If it goes as you suggest it could I am all for it.
I just reflect on how a corporate board has to justify the spending of multiple billions on a company with a tiny market cap. Hence my reasoning.
I knew that a early phase company got bought for a couple billion, but I thought its share price was relatively high compared to ours, before the buy-out.